Noncanonical functions of PARP1 in protection against chromium(VI)
Active Grant Awarded
- Award ID
- R21ES038944
- Recipient
-
Brown University UEI E3FDXZ6TBHW3
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $199,375
Award facts
- Assistance listing
- 93.113 Environmental Health
- Completion date 9% complete
- Place of performance
- Providence, RI 02903, USA
Award details come from USAspending.gov.
About this award
The National Institute of Environmental Health Sciences, within the National Institutes of Health and Department of Health and Human Services, awarded Brown University a $199,375 grant on September 22, 2026, under Assistance Listing 93.113, Environmental Health. Grant R21ES038944 funds research on whether PARP1 protects cells from hexavalent chromium [Cr(VI)] toxicity by repairing covalent topoisomerase I-DNA-protein crosslinks (TOP1-DPCs) that chromium-DNA adducts promote. Two specific aims will determine the role of Cr-DNA adducts in TOP1-DPC formation and PARP1's functions in removing them, and PARP1's importance in suppressing malignant cell transformation by Cr(VI). The project is designed to establish the origin of Cr(VI)'s highly genotoxic damage and PARP1's role in Cr(VI) resistance, with stated applications in exposure biomarkers and chemoprotective strategies. The place of performance is Providence, Rhode Island 02903, USA. The period of performance runs from the September 22, 2026 award date to an ultimate completion date of August 31, 2028. The assistance type is a grant. The source identifies no sub-recipients for this award.
Description
- Abstract
- Hexavalent chromium [CR(VI)] is a potent human carcinogen with widespread occupational exposures in metal-processing industries. CR(VI) is also a common environmental contaminant present in particulate pollution, at numerous superfund sites and in drinking water of many millions of US households. CR(III), the final CR metabolite in cells, forms abundant CR-DNA phosphate adducts as the main form of DNA damage by CR(VI). CR-DNA binding does not cause significant duplex distortions and does not block DNA polymerase activity in vitro. Surprisingly, CR-DNA adducts were mutagenic and genotoxic in cells, pointing to their cellular processing into some more toxic secondary lesions. Based on our new findings, we propose that covalent topoisomerase I-DNA-protein crosslinks (TOP1-DPCS) are these long-elusive secondary DNA lesions promoted by CR-DNA adducts. We also found that PARP1 but not PARP2 induced extensive mono- and polyadpribosylation of proteins and its activity was critical for resistance of cells to CR(VI) toxicity and suppression of genotoxic stress. This project is designed to test our novel hypothesis that the importance of PARP1 in CR(VI) tolerance results from its involvement in repair of highly genotoxic TOP1-DPCS promoted by CR-DNA adducts. Our studies in two specific aims will determine (1) the role of CR-DNA adducts in the formation of TOP1-DPCS and specific functions of PARP1 in their removal and (2) the importance of PARP1 in suppression of malignant cell transformation by CR(VI). The completion of this project will establish the origin of the highly genotoxic damage by CR(VI) and specific functions of PARP1 in CR(VI) resistance. This knowledge is fundamentally important for understanding of CR(VI) carcinogenicity in humans and development of useful biomarkers of exposure and chemoprotective strategies.
Quick answers
Who received award R21ES038944?
R21ES038944 was awarded to Brown University by National Institute of Environmental Health Sciences (National Institutes of Health) on September 22, 2026.
How much is award R21ES038944 worth?
$199,375 has been obligated on R21ES038944.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award